Caris Life Sciences, Inc. Common Stock Earnings Dividend
Earnings Summary
Revenue | $263.71Mn |
Net Profits | $-0.64Mn |
Net Profit Margins | -0.24% |
Caris Life Sciences, Inc. Common Stock’s revenue jumped 45.38% since last year same period to $263.71Mn in the Q2 2026. On a quarterly growth basis, Caris Life Sciences, Inc. Common Stock has generated 21.99% jump in its revenue since last 3-months.
Caris Life Sciences, Inc. Common Stock’s net profit jumped 99.11% since last year same period to $-0.64Mn in the Q2 2026. On a quarterly growth basis, Caris Life Sciences, Inc. Common Stock has generated -24.9% fall in its net profits since last 3-months.
Caris Life Sciences, Inc. Common Stock’s net profit margin jumped 99.39% since last year same period to -0.24% in the Q2 2026. On a quarterly growth basis, Caris Life Sciences, Inc. Common Stock has generated -2.39% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | 0.03 |
EPS Estimate Current Year | 0.03 |
Caris Life Sciences, Inc. Common Stock’s earning per share (EPS) estimates for the current quarter stand at 0.03 - a 400% jump from last quarter’s estimates.
Caris Life Sciences, Inc. Common Stock’s earning per share (EPS) estimates for the current year stand at 0.03.
Key Ratios
Earning Per Share (EPS) | -0.54 |
Caris Life Sciences, Inc. Common Stock’s earning per share (EPS) jumped 51.35% since last year same period to -0.54 in the Q2 2026. This indicates that the Caris Life Sciences, Inc. Common Stock has generated 51.35% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2026-08-05 | -0.01 | -0.54 | -5300% |
2026-05-08 | -0.02 | -0 | 91% |
